Feed RHHBY
RH

Roche Holding AG RHHBY OTC · Healthcare · Switzerland

$60.29 -1.08% -$0.66

Summary

68 / 100 · Bulios Score

What speaks for it

  • Out of every 100 CHF of revenue, 20 CHF is left as net profit.
  • It earns 20 CHF a year on every 100 CHF of invested capital.
  • The share price is below the Bulios Fair Price.

What to watch

  • Revenue fell by 1.3% a year over the last 3 years.

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Score in detail

Price

Is it expensive?

Looks cheap
Bulios Fair Price
Undervalued Price today $60.29

By our assumptions the business is worth more than its shares cost today.

P/E today 25.2 21% higher
5-year average P/E 20.8
P/E today 25.2
Drug Manufacturers - General industry median

Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?

Today you pay 25.2 CHF for 1 CHF of yearly profit. Over the last five years it was 20.8 CHF on average.

Valuation in detail

Is it growing?

It is shrinking

Revenue (CHF)

Diluted EPS (CHF)

  • Analyst estimate

Revenue grew by 1.7% a year over 5 years. Over the last 3 years it fell by 1.3% a year. For the next fiscal year analysts expect revenue to fall by 2.1%. Earnings per share fell by 0.2% a year over the last 3 years.

Growth in detail

Does it make money?

Income figures for the last 12 months are not available.

Profitability in detail

Is it financially healthy?

Its debt is larger than its cash.

Financial health in detail

Does it pay a dividend?

Moderate, stretched
Yield
2.57%
Paid out of profit
65%

You receive $1.55 per share a year. The payout takes a large part of its profit or free cash flow.

Dividends in detail

What do analysts expect?

Neutral

Today's price within the analysts' price targets

The average target of $63 is 4.5% above today's price. 33% of the analysts recommend buying.

Analysts in detail

What does it earn on?

By product

The company reports no revenue by product.

By region

The company reports no revenue by region.

Segments in detail

We use essential cookies to run the website and optional analytics cookies to measure usage.

Privacy policy